Researchers at the University of California, Davis have developed new techniques capable of producing near real-time tissue analysis with quality and accuracy attributes comparable to traditional Haemotoxylin and Eosin (H&E) histopathology methods.
H&E methods can involve multiple tissue or biopsy preparation steps. Thus, these processes typically require elapsed times that are often incompatible with optimal intra-operative decision-making regarding the amount of tissue to be removed during surgery. Therefore, the field of pathology would be advanced – and positive surgical outcomes with reduced side effects would increase – if histopathological processes with reduced time scales were implemented.
Researchers at the University of California Davis have developed a label-free, spectral, pathology method that can quickly identify regions of diseased tissue in vivo without the need for traditional hematoxylin and eosin staining. A multimodal microscope capable of acquiring varied and simultaneous microscopy/spectroscopy images of unstained tissue can survey the tissue structure and architecture, and - by comparing unique tissue signatures provided by the microscope, discriminate between diseased and healthy cells. This method overcomes historical limitations associated with current approaches to intra-operative histopathology.
Country | Type | Number | Dated | Case |
United States Of America | Published Application | 2022038693 | 12/08/2022 | 2019-580 |
Patent Cooperation Treaty | Published Application | 2021/092489 | 06/24/2021 | 2019-580 |
Pathology, Histopathology, Inter-operative, Label-free